About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

In this week’s Bloom Boost – health news you might have missed, Gayle Guyardo the host of the nationally syndicated health and wellness show Bloom  shares U.S. senators are ...

(HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster ...

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.

Sen. Bernie Sanders (I-Vt.) noted that Novo Nordisk’s weight loss drug Ozempic sells for $969 a month in the U.S. but for ...

Fox News anchor Bret Baier has pointed the finger at former President Donald Trump, not Vice President Kamala Harris, for the ...

If these preliminary findings are more widely applicable, opioid use disorder would be added to the long list of ailments potentially reduced by Ozempic.

The Senate Committee on Health, Education, Labor and Pensions held a hearing on Tuesday, to discuss Novo Nordisk lowering ...

Novo Nordisk CEO Lars Fruergaard Jørgensen faced Senate scrutiny over the high prices of Wegovy and Ozempic as U.S. demand ...

Novo Nordisk CEO Lars Fruergaard Jorgensen testified before the Senate Health, Education, Labor and Pensions Committee hearing in ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...